October 7, 2015
SMS Co., Ltd.(Securities Code: 2175 / TSE1 )
Additional Presentation Materials for
acquisition of MIMS Group
Pharmaceutical
Companies
Healthcare Professionals
(doctors, nurses,
pharmacists)
Healthcare Institutions
(hospitals, clinics,
pharmacies)
・Listing in
drug database
・Drug database
・Healthcare news,
educational contents
・Drug database
・Pharmaceutical
checking tool
・Drug information
(publishing)
Usage
fee
Publishing
fee
Service Provision Area: Singapore, China, Hong
Kong, South Korea, India, Indonesia, Malaysia,
Philippines, Thailand, Myanmar, Vietnam
1.Organizing and summarizing detailed drug information
provided by pharmaceutical companies individually in
various formats into formats easily readable by healthcare
professionals, and providing this to them through a variety of
media including print media, websites, and mobile
applications.
Service Provision Area: Australia, New Zealand,
South Korea, Singapore
2.Providing drug information to healthcare professionals
through online and print media, and providing verification
tools to hospital core systems necessary to increase the
accuracy of pharmaceutical prescriptions
1. MIMS Group Business
© Copyright SMS CO.,LTD
Brand value
SMS Co., Ltd.
Membership
base of
healthcare
professionals
2. Strength of SMS, Mitsui and MIMS
Online communities
Career-related
services
Management support
services Business
relationship
with
pharmaceutical
companies
Know-how of
developing and operating
information services
Medical/Healthcare
Network in Asia
Mitsui & Co., Ltd.
IHH Healthcare(One of the Largest Private Healthcare Group in Asia)
Singapore
4 hospitals/over 50 clinics/
3 related businesses
Turkey
15 hospitals/12 clinics/
4 related businesses
India2 hospitals
(1 of 2 is JV)
/1 related business
China
1 hospital (Hospital
Management)/11 clinics
Hong Kong
1 clinic
Malaysia
13 hospitals/1 clinic/
4 related businesses
Brunei
1 hospital (JV)
Vietnam
1 hospital
(Hospital Management)
China
Shenzhen Main Luck
(Drug Manufacturing &
Sales)
India
Japan
MicroBiopharm Japan
(CMO Business)
Fuji Pharma
(Drug Manufacturing & Sales)
Sogo Medical
(Management Support to
Clinic, dispensing
pharmacy)ThailandKeimed
(Drug Wholesaling)
Hokendojin
(Healthcare Info Provider)Olic
(CMO Business)
Iraq
1 hospital
(Hospital Management)
UAE
1 hospital
(Hospital Management)
※Macedonia located in the Balkan Peninsula: 1 hospital
Hospital-related and Pharmaceutical Business
MIMS Group
Claris Otsuka
(Infusion Solution)
© Copyright SMS CO.,LTD
CSOCRO
CIS
(Clinic
Information
System)
CMS
(Clinic
Management
System)
R&D
e-detailing
SMO
Sales &
Marketing
MIMS business
Outside partners
Pharmaceutical field Clinic field
Marketing Support to
Pharmaceutical companiesManagement support to Clinics
Pharma-
ceutical
companies
Healthcare
Professionals
3. MIMS growth strategy
MR
digitization
MR
education
Pharma
Research
company
Medicine
wholesaler
Medication
management
SFA
Market
research
Phase
4
Clinical trial
recruitment
Multinational
clinical trial
Pharma
DB
Medical
devicesSales
promotion
support
company
Recruiting
agency
Education
Support
company
Financial
institution
Career
Patient
collecting
Procurement
Document
management
Patient
management
Medical
record
Medical
prescription
Consulting
Firm
Financing
Private
Practice
support
Education
© Copyright SMS CO.,LTD
Medica Asia (Holdco) Limited
(U.K)
MIMS PTE. LTD.
(Singapore)
MIMS (Hong Kong) Limited
(Hong Kong)
MIMS Medica Sdn Bhd
(Malaysia)
SMS Mitsui
60% 40%
・・・ + 16 companies
4. Investment Diagram
MIMS Group
※ 19 companies covering 12 countries
© Copyright SMS CO.,LTD
5. MIMS Group Profile
Establishment 1963
Sales Amount US$47.4 million(FY12/2014)
Employees 468(as of December 2014)
Business Territories
Singapore, China, Hong Kong, South Korea, India, Indonesia, Philippines, Thailand, Malaysia, Vietnam, Myanmar, Australia, New Zealand
Number of Members
1.7 million memberships(including 400 thousand doctors)
MIMS Group
Business Territories MIMS Group
© Copyright SMS CO.,LTD
These materials contain forward-looking statements, including estimates, projections, and statements related to business
operations of SMS CO., LTD. (hereinafter referred to as the “Company”).
The forward-looking statements are based on current expectations and assumptions in light of the information available to
the Company as of October 7, 2015 and are subject to significant risks and uncertainties. The results or events predicted in
these forward-looking statements may differ materially from actual results or events.
As a result, we cannot guarantee that any forward-looking statements will materialize nor do we undertake any obligation to
update or revise publicly any of these forward-looking statements.
For any inquiries on the materials, please contact below:
SMS Co., Ltd.
Corporate Planning Department
E-mail: [email protected]
Phone: +81-3-6721-2403
Caution on Forward-Looking Statements